María Eugenia Inda

Maria Eugenia Inda is currently a Pew Post-Doctoral Fellow with the Synthetic Biology Center, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA. She is building biosensors to diagnose and treat inflammatory disorders in the gut, such as inflammatory bowel disease and celiac disease. Specifically, she is equipping the bacteria dwelling in the intestines with sensors to recognize the molecular markers of inflammation and command them as sentinels to patrol the gut and secrete therapeutic molecules in situ. In 2019, she started and leads the MIT Microbiome Journal Club with the support of the Center for Microbiome Informatics and Therapeutics (CMIT), MIT/Massachusetts General Hospital (MGH), Boston, MA, USA. Besides, she is thrilled to serve as an MIT-Comm Lab Advisor using her prowess to help students show the value of their ideas and push their scientific career forward. Dr. Inda is also the 2020 Langer Fellow for Innovation and Entrepreneurial Excellence—American Institute of Chemical Engineers (AIChE). She was a Topic Editor of Biosensors (MDPI) in 2020 and an MIT IMPACT Fellow in 2017.